Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, October 16, 2009
Thu, October 15, 2009 YONG, WOSCY, ETLO, LFVN, NRIFF Have Been Added To Naked Short Lists Today
October 15, 2009 /M2 PRESSWIRE/ BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short threshold lists. Yongye International (NASDAQ: YONG), Wolseley Plc (OTC: WOSCY), Etelos (OTC: ETLO), Lifevantage (OTCBB: LFVN) and Nuvo Research (OTC: NRIFF). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
Yongye International, Inc. (NASDAQ: YONG), together with its subsidiaries, engages in the research and development, manufacturing, and distribution of fulvic acid based liquid and powder nutrient compounds for plant and animal feed used in the agriculture industry in the Peoplea�s Republic of China. It sells two lines of product based on its fulvic acid base, including plant nutrition liquid compound and animal nutrition food additive. The companya�s plant products add naturally occurring macro and micro nutrients, such as nitrogen, phosphorus, potassium, boron, and zinc; and animal products add natural herbs, which provide antibiotic type properties. It sells its products through corporate direct sales, community-direct sales, and distributor network sales, as well as through a branded store network. As of March 31, 2009, the company operated 2000 branded stores. The company was formerly known as Yongye Biotechnology International, Inc. and changed its name to Yongye International, Inc. as a result of merger with Yongye International, Inc. in June 2009. Yongye International is headquartered in Beijing, the Peoplea�s Republic of China. There is a failure to deliver in shares of YONG.
Wolseley plc (OTC: WOSCY) engages in the distribution of heating and plumbing products to the professional market, as well as supplies building materials in Europe and North America. It distributes various products, including plumbing, heating, and air conditioning comprising baths, showers and accessories, sanitaryware, brassware, bathroom furniture, boilers and burners, radiators and valves, hot water cylinders and flues, control equipment, and ventilation/air conditioning equipment; and building materials, such as insulation, plaster and plasterboard, roofing materials, bricks, blocks and aggregates, tiles and flooring, timber products, doors and frames, glass, beams and trusses, and hardware. The company also distributes electrical products, including cables and cabling accessories, controls and switchgear, wiring accessories, lighting, data networking supplies, and cable management products; and civils/waterworks, industrial, and commercial products, such as tanks and treatment plants, sheet material, drainage pipes and associated supplies, underground pressure pipes, small bore pressure pipes and fittings, and other pipes and valves. Further, it involves in the provision of construction labour, secured lending to house builders, customer inventory management, hire of plant and tools, and maintenance contracts. As of July 31, 2008, the company operated 5,310 branches in 27 countries. Wolseley was founded in 1887 and is headquartered in Reading, the United Kingdom. There is a failure to deliver in shares of WOSCY.
Etelos, Inc. (OTC: ETLO) provides tools and services for the development and distribution of Web applications. It also provides a software-as-a-service (SaaS) ecosystem for building, distributing, and using Web applications, including a marketplace to deploy and support them. The company enables software manufacturers to migrate existing applications or create new applications, as well as involves in the package, distribution, hosting, billing, marketing, and supporting SaaS enabled applications through private label applications marketplaces. Etelos, Inc. develops products for Web applications, which include open standards-based tools, such as the Etelos Application Server and the Etelos Development Environment that support various common programming languages; and the English Application Scripting Engine, an open standards-based scripting language for Web developers, businesses, and individual users. In addition, the company offers Etelos Platform Suite, which allows third parties to use its software platforms and services to develop a private label application and marketplace; Etelos Ad Serve, an on-demand system for purchasing or publishing advertising in the Etelos ecosystem; and Etelos Web Application Hosting. Further, it provides professional services, and customer support and management services. The companya�s marketplace supports and encourages communities of developers, distributors, and consumers to expand their offerings, collaborate on new ideas and improvements, and provide scalable solutions using Web applications available to others. Etelos, Inc. offers its products and services in North America, South America, Europe, and the Asia-Pacific region. The company was founded in 1999 and is headquartered in Maple Valley, Washington. There is a failure to deliver in shares of ETLO.
Lifevantage Corporation (OTCBB: LFVN), a dietary supplement company, manufactures, markets, distributes, and sells dietary supplements in the United States and internationally. The company primarily offers Protandim, a patented dietary supplement that increases the bodya�s natural antioxidant protection by inducing protective enzymes, including superoxide dismustase and catalase. It sells its products through network marketing, direct to consumer, and retail sales channels. Lifevantage Corporation was founded in 2003 and is headquartered in San Diego, California. There is a failure to deliver in shares of LFVN.
Nuvo Research Inc. (OTC: NUVO) primarily focuses on the research and development of drug products that are delivered to and through the skin in Canada. It develops drugs based on two technology platforms, transdermal drug delivery and immune system regulation. The companya�s lead products include Pennsaid, a topical non-steroidal anti-inflammatory drug, which is used to treat the pain and symptoms of osteoarthritis of the knee; and Pennsaid Plus, a pre clinical stage product used for applications in various therapeutic areas. Nuvo Research Inc. markets its Pennsaid products in Canada and the Caribbean, as well as in European countries, such as Greece, Italy, and the United Kingdom. Its products also comprise Oxoferin, a topical wound healing agent; and WF10, a chlorite-based, immunomodulating drug, which is in the Phase II clinical trial used for the treatment of inoperable pancreatic cancer. It markets its Oxoferin drug in Europe, Asia, and South America under the Oxoferin and Oxovasin trade names. The company was formerly known as Dimethaid Research, Inc. and changed its name to Nuvo Research Inc. in September 2005. Nuvo Research Inc. was founded in 1983 and is headquartered in Mississauga, Canada. There is a failure to deliver in shares of NRIFF.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2.650,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
Contact: Thomas Ronk / CEO / www.BUYINS.net / (800) 715-9999 / tom@buyins.net
